Oscar Health (OSCR) Stock Forecast & Price Target

$13.93 +0.43 (+3.19%)

(As of 09:34 AM ET)

Oscar Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 9 Analyst Ratings

Sell
2

Hold
2

Buy
5

Based on 9 Wall Street analysts who have issued ratings for Oscar Health in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 2 have given a sell rating, 2 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for OSCR.

Consensus Price Target

$21.56
54.79% Upside

According to the 9 analysts' twelve-month price targets for Oscar Health, the average price target is $21.56. The highest price target for OSCR is $28.00, while the lowest price target for OSCR is $12.00. The average price target represents a forecasted upside of 54.79% from the current price of $13.93.

Get the Latest News and Ratings for OSCR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oscar Health and its competitors.

OSCR Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	2 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	3 Hold rating(s)
Sell	2 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$21.56	$22.93	$24.17	$7.70
Forecasted Upside	54.79% Upside	43.48% Upside	3.85% Upside	-3.87% Downside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Hold

"X-Ray Vision" could find thousands of hidden market opportunities (Ad)

Let me show you how I trade with “X-Ray vision.” You see, most “trend” traders only use one trend filter when looking for an optimal buy signal. And that can be a big mistake because you can’t see if you’re in a “True Trend.” But my newest trading tool is designed to only target the best, most stable stocks… Using 3 trend filters… which are these green, yellow, and red lines.

Just tap here to join the presentation.

OSCR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

OSCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oscar Health Stock vs. The Competition

Type	Oscar Health	Finance Companies	S&P 500
Consensus Rating Score	2.44	2.49	2.51
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	59.72% Upside	13.20% Upside	12.02% Upside
News Sentiment Rating	Positive News See Recent OSCR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/10/2024	Jefferies Financial Group 2 of 5 stars		Initiated Coverage	Underperform	$12.00	-27.56%
11/6/2024	Bank of America 3 of 5 stars		Downgrade	Neutral ➝ Underperform	$21.00 ➝ $13.50	-26.35%
10/7/2024	UBS Group 4 of 5 stars		Initiated Coverage	Neutral	$23.00	+14.20%
9/10/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$28.00 ➝ $28.00	+60.73%
6/12/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$24.00 ➝ $27.00	+34.90%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
Could this be the hottest crypto discovery of all time? (Ad) I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free… If you want in, Just Click Here
5/30/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$28.00	+38.75%
5/9/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$16.00 ➝ $21.00	+1.20%
3/22/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$20.00	+45.40%
8/30/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$5.00 ➝ $7.50	+17.55%
8/9/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$7.00 ➝ $8.50	+6.38%
2/14/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform	$3.00 ➝ $6.00	+13.42%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:55 AM ET.

OSCR Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Oscar Health is $21.56, with a high forecast of $28.00 and a low forecast of $12.00.
: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There are currently 2 sell ratings, 2 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OSCR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSCR, but not buy additional shares or sell existing shares.
: According to analysts, Oscar Health's stock has a predicted upside of 54.79% based on their 12-month stock forecasts.
: Over the previous 90 days, Oscar Health's stock had 1 downgrade by analysts.
: Oscar Health has been rated by research analysts at Bank of America, Jefferies Financial Group, and UBS Group in the past 90 days.
: Analysts like Oscar Health less than other "finance" companies. The consensus rating score for Oscar Health is 2.44 while the average consensus rating score for "finance" companies is 2.49. Learn more on how OSCR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available

This page (NYSE:OSCR) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oscar Health (OSCR) Stock Forecast & Price Target